Sylvia H Yeh

Summary

Affiliation: Los Angeles Biomedical Research Institute
Country: USA

Publications

  1. ncbi PEDIARIX: clinical trials
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA, 1124 W Carson St, Liu Research Building, Torrance, CA 90502, USA
    Expert Rev Vaccines 4:139-45. 2005
  2. ncbi Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?
    Sylvia H Yeh
    UCLA Center for Vaccine Research at Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, 1124 W Carson Street, Torrance, CA 90502, USA
    Drugs 66:731-41. 2006
  3. ncbi Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers
    Sylvia H Yeh
    Vaccine Research Center, Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, 1124 West Carson St, Liu Research Building, Torrance, CA 90502, USA
    Pediatrics 126:e493-505. 2010
  4. ncbi Pertussis: persistent pathogen, imperfect vaccines
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Research and Education Institute at Harbor UCLA Medical Center, Department of Pediatrics, Torrance, CA 90502, USA
    Expert Rev Vaccines 2:113-27. 2003
  5. ncbi Update on adolescent immunization: pertussis, meningococcus, HPV, and the future
    Sylvia H Yeh
    University of California, Los Angeles, USA
    Cleve Clin J Med 74:714-6, 719-27. 2007
  6. ncbi Paralytic syndromes in children: epidemiology and relationship to vaccination
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Neurol 42:206-12. 2010
  7. ncbi Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, 1124 W Carson Street, Liu Research Building, Torrance, CA 90502, USA
    Vaccine 21:2627-31. 2003
  8. ncbi Cost-benefit analysis of in-hospital influenza vaccination of postpartum women
    Yao Ding
    Leonard Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, California, USA
    Obstet Gynecol 119:306-14. 2012

Detail Information

Publications8

  1. ncbi PEDIARIX: clinical trials
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA, 1124 W Carson St, Liu Research Building, Torrance, CA 90502, USA
    Expert Rev Vaccines 4:139-45. 2005
    ..This vaccine is indicated for the prevention of diphtheria, tetanus, pertussis, hepatitis B and poliovirus. This article reviews the available data regarding the vaccine's immunogenicity and safety...
  2. ncbi Shift in the epidemiology of pertussis infection: an indication for pertussis vaccine boosters for adults?
    Sylvia H Yeh
    UCLA Center for Vaccine Research at Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, 1124 W Carson Street, Torrance, CA 90502, USA
    Drugs 66:731-41. 2006
    ..With the recent availability of acellular pertussis vaccines for older children to adults, consideration of a change in current vaccination policy is necessary in order to provide better disease control...
  3. ncbi Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in infants and toddlers
    Sylvia H Yeh
    Vaccine Research Center, Los Angeles Biomedical Research Institute, Harbor UCLA Medical Center, 1124 West Carson St, Liu Research Building, Torrance, CA 90502, USA
    Pediatrics 126:e493-505. 2010
    ..13-Valent pneumococcal conjugate vaccine (PCV13) (PCV7 serotypes plus 1, 3, 5, 6A, 7F, and 19A) was designed to provide broader pneumococcal disease coverage. We evaluated the immunogenicity and safety of PCV13 compared with PCV7...
  4. ncbi Pertussis: persistent pathogen, imperfect vaccines
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Research and Education Institute at Harbor UCLA Medical Center, Department of Pediatrics, Torrance, CA 90502, USA
    Expert Rev Vaccines 2:113-27. 2003
    ..New methodologies for understanding disease pathogenesis, immune responses and vaccine development are needed to effectively interrupt continued transmission of this pathogen...
  5. ncbi Update on adolescent immunization: pertussis, meningococcus, HPV, and the future
    Sylvia H Yeh
    University of California, Los Angeles, USA
    Cleve Clin J Med 74:714-6, 719-27. 2007
    ..Routinely scheduled visits for 11- to 12-year-olds will allow for immunization against these and other diseases and give us an opportunity to provide anticipatory guidance against high-risk behaviors...
  6. ncbi Paralytic syndromes in children: epidemiology and relationship to vaccination
    Kenneth M Zangwill
    UCLA Center for Vaccine Research, Los Angeles Biomedical Research Institute at Harbor UCLA Medical Center, Torrance, CA 90502, USA
    Pediatr Neurol 42:206-12. 2010
    ....
  7. ncbi Heptavalent pneumococcal vaccine conjugated to outer membrane protein of Neisseria meningitidis serogroup b and nasopharyngeal carriage of Streptococcus pneumoniae in infants
    Sylvia H Yeh
    UCLA Center for Vaccine Research, Harbor UCLA Medical Center, 1124 W Carson Street, Liu Research Building, Torrance, CA 90502, USA
    Vaccine 21:2627-31. 2003
    ..Streptococcus pneumoniae (Sp) is an important bacterial pathogen in children. Nasopharyngeal (NP) colonization of S. pneumoniae is necessary for person-to-person transmission and often precedes invasive disease...
  8. ncbi Cost-benefit analysis of in-hospital influenza vaccination of postpartum women
    Yao Ding
    Leonard Schaeffer Center for Health Policy and Economics, University of Southern California, Los Angeles, California, USA
    Obstet Gynecol 119:306-14. 2012
    ..To estimate the potential economic benefits associated with hospital-based postpartum influenza vaccination...